Get the Stockscreener App
40.05
6.12%
-2.61
Inspire Medical Systems Inc stock is traded at $40.05, with a volume of 1.68M.
It is down -6.12% in the last 24 hours and down -29.29% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
See More
Previous Close:
$42.66
Open:
$43.3
24h Volume:
1.68M
Relative Volume:
1.37
Market Cap:
$1.15B
Revenue:
$915.25M
Net Income/Loss:
$131.14M
P/E Ratio:
8.9557
EPS:
4.472
Net Cash Flow:
$96.71M
1W Performance:
-9.51%
1M Performance:
-29.29%
6M Performance:
-53.62%
1Y Performance:
-73.24%
1-Day Range:
$39.61
$43.94
1-Week Range:
$39.61
$45.09
52-Week Range:
$39.61
$153.07
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
40.05 | 1.23B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
84.47 | 147.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
306.76 | 117.12B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
76.15 | 98.82B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
52.68 | 79.59B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
81.38 | 46.84B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-12-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Inspire Medical Systems (INSP) price target decreased by 17.14% to 72.73 - MSN
Insider Sell Alert: John Rondoni Sells 700 Shares of Inspire Med - GuruFocus
[144] Inspire Medical Systems, Inc. SEC Filing - Stock Titan
Inspire Medical (INSP) officer sells 700 shares at about $43 - Stock Titan
Wellington Group reports 2.54M Inspire shares (INSP) representing 8.81% stake - Stock Titan
[SCHEDULE 13G/A] Inspire Medical Systems, Inc. Amended Passive Investment Disclosure - Stock Titan
INSP (NYSE) Form 144: Director/Holder Notices Sale of 700 Shares via Morgan Stanley - Stock Titan
How (INSP) Movements Inform Risk Allocation Models - Stock Traders Daily
Transcript : Inspire Medical Systems, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08 - marketscreener.com
5 Insightful Analyst Questions From Inspire Medical Systems’s Q1 Earnings Call - Yahoo Finance
What Does The Future Hold For Inspire Medical Systems, Inc. (NYSE:INSP)? These Analysts Have Been Cutting Their Estimates - 富途牛牛
A Look At Inspire Medical Systems (INSP) Valuation After Forecast Downgrades And Guidance Reset - Sahm
Inspire Medical Systems stock hits 52-week low at $43.01 By Investing.com - Investing.com Nigeria
Inspire Medical Systems stock hits 52-week low at $43.01 - Investing.com
Inspire Medical Systems director Shawn McCormick sells $31,535 stock - Investing.com UK
Inspire Medical Systems director Shawn McCormick sells $31,535 stock By Investing.com - Investing.com South Africa
Director at Inspire Medical (NYSE: INSP) sells 696 company shares - Stock Titan
Things Look Grim For Inspire Medical Systems, Inc. (NYSE:INSP) After Today's Downgrade - Yahoo Finance
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Is a 20.50% Potential Upside Worth the Investment? - DirectorsTalk Interviews
INSP Technical Analysis | Trend, Signals & Chart Patterns | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Outlook And Filing Share Offering – Has The Bull Case Changed? - Sahm
Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Guidance Amid Reimbursement ChallengesWhat's Changed - Yahoo Finance
Inspire Medical Systems, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:INSP) 2026-05-08 - Seeking Alpha
INSP SEC FilingsInspire Medical 10-K, 10-Q, 8-K Forms - Stock Titan
INSP Maintained by Oppenheimer -- Rating Remains at Perform - GuruFocus
Inspire Medical Systems Inc (INSP) Stock News & Articles - 24/7 Wall St.
symbol__ Stock Quote Price and Forecast - CNN
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $56 - Moomoo
Inspire Medical Systems (INSP) Q1 earnings and revenues top estimates - MSN
Inspire Medical Systems stock hits 52-week low at $45.00 By Investing.com - Investing.com Australia
Inspire Medical Systems reports loss of USD 1.1M in Q1 2026 - Medical Buyer
Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip (NYSE:INSP) - Seeking Alpha
Inspire Medical Shareholders Approve Board Declassification and Governance Changes - TipRanks
Investors back new equity plan and board changes at Inspire Medical (NYSE: INSP) - Stock Titan
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down - Zacks Investment Research
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - Barchart.com
Inspire Medical Systems Faces Limited Visibility, RBC Says - marketscreener.com
Stifel cuts Inspire Medical stock price target on weak guidance By Investing.com - Investing.com Canada
Inspire Medical Systems Q1 2026 earnings preview - MSN
Piper Sandler Downgrades Inspire Medical Systems to Neutral From Overweight, $85 Price Target - Moomoo
Inspire Medical Systems Is Maintained at Hold by Truist Securities - Moomoo
Inspire Medical Systems stock hits 52-week low at $45.00 - Investing.com
Inspire Medical Systems Sees 2026 EPS 7c-EPS 62c >INSP - Moomoo
Inspire Medical Systems Sees 2026 Adj EPS 75c-Adj EPS $1.25 >INSP - Moomoo
Inspire Medical Systems, Inc. Reports Q1 2026 Financial Results and Forward-Looking Statements - Minichart
RBC Cuts Price Target on Inspire Medical Systems to $45 From $56, Keeps Sector Perform Rating - marketscreener.com
Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED) - Benzinga
Truist Securities Adjusts Price Target on Inspire Medical Systems to $50 From $64, Maintains Hold Rating - marketscreener.com
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2026 Earnings Call Transcript - Insider Monkey
BofA cuts Inspire Medical stock rating on reimbursement concerns By Investing.com - Investing.com Canada
Mizuho cuts Inspire Medical Systems stock price target on guidance reduction - Investing.com Canada
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):